The North America non-energy based aesthetic treatment market size is anticipated to reach USD 45.3 billion by 2030, registering a CAGR of 13.9% from 2023 to 2030. The increasing prevalence of skin conditions and the rising geriatric population contributes largely to the high demand for non-invasive treatment procedures.
The demand for aesthetic procedures is increasing, and reimbursements for traditional insurance-based medicine are declining. An increasing number of medical practitioners, regardless of their specialties, are engaged in medical aesthetic practices, such as performing procedures in their offices or practicing in medical spas.
Minimally invasive surgeries offer advantages, including smaller incisions, shorter hospital stays, rapid wound healing, lesser pain, fewer surgical wounds, and a lower risk of complications than invasive surgeries. Moreover, the effectiveness and results of minimally invasive surgeries are similar to conventional surgical treatments. According to the data published by the International Society of Aesthetic Plastic Surgery, in 2021, approximately 17,598,888 non-surgical cosmetic procedures were performed globally. These factors would positively impact the market growth.
Furthermore, several initiatives by the key market players, such as new product launches and strategic alliances, have contributed to the market growth. For instance, in January 2023, Allergan plc, an AbbVie company, announced to start off an initiative called “Discover your 360°,” which mainly focuses on promoting non-surgical aesthetic treatments. It is a customer-centric approach that offers cutting-edge technologies and products to meet the growing need of patients and practitioners.
Similarly, in January 2023, Galderma launched an innovative augmented reality application, FACE by Galderma. The solution would enable aesthetic patients and practitioners to identify treatment results at the planning stage.
The demand for aesthetic procedures is increasing, and reimbursements for traditional insurance-based medicine are declining. An increasing number of medical practitioners, regardless of their specialties, are engaged in medical aesthetic practices, such as performing procedures in their offices or practicing in medical spas.
Minimally invasive surgeries offer advantages, including smaller incisions, shorter hospital stays, rapid wound healing, lesser pain, fewer surgical wounds, and a lower risk of complications than invasive surgeries. Moreover, the effectiveness and results of minimally invasive surgeries are similar to conventional surgical treatments. According to the data published by the International Society of Aesthetic Plastic Surgery, in 2021, approximately 17,598,888 non-surgical cosmetic procedures were performed globally. These factors would positively impact the market growth.
Furthermore, several initiatives by the key market players, such as new product launches and strategic alliances, have contributed to the market growth. For instance, in January 2023, Allergan plc, an AbbVie company, announced to start off an initiative called “Discover your 360°,” which mainly focuses on promoting non-surgical aesthetic treatments. It is a customer-centric approach that offers cutting-edge technologies and products to meet the growing need of patients and practitioners.
Similarly, in January 2023, Galderma launched an innovative augmented reality application, FACE by Galderma. The solution would enable aesthetic patients and practitioners to identify treatment results at the planning stage.
North America Non-energy Based Aesthetic Treatment Market Report Highlights
- By procedure, injectables held the largest aesthetic treatment market share in 2022 and are expected to expand at the fastest CAGR of more than 14.1% from 2023 to 2030
- Based on end-use, the med spa segment dominated the aesthetic treatment market in 2022. The segment is expected to continue its dominance throughout the forecast period
- The introduction of various insurance schemes for cosmetic procedures has contributed to increasing the awareness, acceptance, and growth of this market
- Increasing adoption of minimally invasive surgeries, coupled with the availability of a wide range of minimally invasive treatment options, is driving the growth of the aesthetic treatment market
- Various manufacturers focus on technological innovations, new treatment launches, collaboration, and expansion as major strategic initiatives
Table of Contents
Chapter 1 Research Method1.1 Information procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.2 Market Restraint Analysis
3.2 North America non-energy Based aesthetic Treatment - PESTLE Analysis
3.3 Industry Analysis - Porter’s
3.4 COVID-19 Impact Analysis
Chapter 4 North America non-energy Based aesthetic Treatment Market: Procedure Estimates & Trend Analysis
4.1 North America non-energy Based aesthetic treatment market: Procedure movement analysis
4.1.1 Injectables
4.1.1.1 Injectables market, 2018 - 2030 (USD Million)
4.1.1.2 Botulinum Toxin
4.1.1.2.1 Botulinum toxin market, 2018 - 2030 (USD Million)
4.1.1.3 Calcium Hydroxylapatite
4.1.1.3.1 Calcium hydroxylapatite market, 2018 - 2030 (USD Million)
4.1.1.4 Hyaluronic Acid
4.1.1.4.1 Hyaluronic acid market, 2018 - 2030 (USD Million)
4.1.1.5 Polymer Filler
4.1.1.5.1 Polymer filler market, 2018 - 2030 (USD Million)
4.1.1.6 Collagen
4.1.1.6.1 Collagen market, 2018 - 2030 (USD Million)
Chapter 5 North America non-energy Based aesthetic Treatment Market: End-Use Estimates & Trend Analysis
5.1 North America non-energy Based aesthetic Treatment market: End-use movement analysis
5.1.1 Hospital/Surgery Center
5.1.1.1 Hospital/Surgery center market, 2018 - 2030 (USD Million)
5.1.2 Medspa
5.1.2.1 Medspa market, 2018 - 2030 (USD Million)
5.1.3 Traditional Spa
5.1.3.1 Traditional spa market, 2018 - 2030 (USD Million)
5.1.4 HCP owned clinic
5.1.4.1 HCP owned clinic market, 2018 - 2030 (USD Million)
Chapter 6 Regional Estimates & Trend Analysis, by Procedure and End-Use
6.1 North America non-energy Based aesthetic treatment market share by region, 2022 & 2030
6.2 North America
6.2.1 North America non-energy Based aesthetic treatment market, 2018 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. non-energy Based aesthetic treatment market, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada non-energy Based aesthetic treatment market, 2018 - 2030 (USD Million)
Chapter 7 Competitive Landscape
7.1 Recent Development by Key Market Players
7.2 Company/Competition Categorization (Key Innovators, Market Leaders)
7.2.1 PARTICIPANT CATEGORIZATION
7.3 North America non-energy Based aesthetic treatment- market share analysis
7.4 Company Profiles
7.4.1 Allergan plc (AbbVie)
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 Galderma
7.4.2.1 Company Overview
7.4.2.2 Financial performance
7.4.2.3 Product Benchmarking
7.4.2.4 Strategic Initiatives
7.4.3 Merz Pharma
7.4.3.1 Company Overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.4 LPG SYSTEMS
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 NeoGenesis, Inc.
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.6 Oxygenceuticals
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Product benchmarking
7.4.6.4 Strategic initiatives
7.4.7 Genesis Biosystems, Inc.
7.4.7.1 Company overview
7.4.7.2 Product benchmarking
7.4.8 Revance Therapeutics, Inc.
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
7.4.9 Ipsen Pharma
7.4.9.1 Company overview
7.4.9.2 Product benchmarking
7.4.9.3 Strategic initiatives
7.4.10 Suneva Medical, Inc.
7.4.10.1 Company overview
7.4.10.2 Financial performance
7.4.10.3 Product benchmarking
7.4.10.4 Strategic initiatives
7.4.11 Mesoestetic Pharma Group SL
7.4.11.1 Company overview
7.4.11.2 Financial performance
7.4.11.3 Product benchmarking
7.4.11.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market summary (USD Million, 2022)
Fig. 7 Market trends & outlook
Fig. 8 Market segmentation & scope
Fig.9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 North America Non-energy based Aesthetic Treatment PESTLE Analysis
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 COVID-19 Impact Analysis
Fig. 14 North America non-energy based aesthetic treatment market procedure outlook key takeaways
Fig. 15 North America non-energy based aesthetic treatment market: Procedure movement analysis
Fig. 16 Injectables market, 2018 - 2030 (USD Million)
Fig. 17 Botulinum toxin market, 2018 - 2030 (USD Million)
Fig. 18 Calcium hydroxyl apatite market, 2018 - 2030 (USD Million)
Fig. 19 Hyaluronic acid market, 2018 - 2030 (USD Million)
Fig. 20 Polymer filler market, 2018 - 2030 (USD Million)
Fig. 21 Collagen market, 2018 - 2030 (USD Million)
Fig. 22 Skin rejuvenation market, 2018 - 2030 (USD Million)
Fig. 23 Chemical peel market, 2018 - 2030 (USD Million)
Fig. 24 Microdermabrasion market, 2018 - 2030 (USD Million)
Fig. 25 Micro needling market, 2018 - 2030 (USD Million)
Fig. 26 North America non-energy based aesthetic treatment market end-use outlook key takeaways
Fig. 27 North America non-energy based aesthetic treatment market: End-use movement analysis
Fig. 28 Hospital/Surgery center market, 2018 - 2030 (USD Million)
Fig. 29 Med spa market, 2018 - 2030 (USD Million)
Fig. 30 Traditional spa market, 2018 - 2030 (USD Million)
Fig. 31 HCP owned clinic market, 2018 - 2030 (USD Million)
Fig. 32 Regional market place: Key takeaways
Fig. 33 Regional outlook, 2022 & 2030
Fig. 34 North America non-energy based aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 35 U.S. non-energy based aesthetic treatment market, 2018 - 2030 (USD Million)
Fig. 36 Canada non-energy based aesthetic treatment market, 2018 - 2030 (USD Million)
Companies Mentioned
- Allergan plc (AbbVie)
- Galderma
- Merz Pharma
- LPG SYSTEMS
- NeoGenesis, Inc.
- Oxygenceuticals
- Genesis Biosystems, Inc.
- Revance Therapeutics, Inc.
- Ipsen Pharma
- Suneva Medical, Inc.
- Mesoestetic Pharma Group SL
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | February 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 16.1 Billion |
| Forecasted Market Value ( USD | $ 45.3 Billion |
| Compound Annual Growth Rate | 13.9% |
| Regions Covered | North America |
| No. of Companies Mentioned | 11 |
